Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Carlsmed (CARL) Invested Capital (2024 - 2025)

Carlsmed's Invested Capital history spans 2 years, with the latest figure at $114.5 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 307.36% year-over-year to $114.5 million; the TTM value through Dec 2025 reached $114.5 million, up 307.36%, while the annual FY2025 figure was $114.5 million, 307.36% up from the prior year.
  • Invested Capital reached $114.5 million in Q4 2025 per CARL's latest filing, down from $122.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $122.1 million in Q3 2025 to a low of -$67.6 million in Q2 2025.